|By PR Newswire||
|October 23, 2013 08:05 AM EDT||
NEW YORK, October 23, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting CareFusion Corporation (NYSE: CFN), DaVita HealthCare Partners, Inc. (NYSE: DVA), MAKO Surgical Corp. (NASDAQ: MAKO), Waters Corporation (NYSE: WAT), and Health Management Associates, Inc. (NYSE: HMA). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
CareFusion Corporation Research Report
On October 9, 2013, CareFusion Corporation (CareFusion) announced that it intends to release its Q1 FY 2014 (period ended September 30, 2013) results on Thursday, November 7, 2013, after the close of trading on NYSE. The Company informed that it will also host a conference call on the same day at 2:00 p.m. PST (5:00 p.m. EST), to discuss the financial results, which will be accessible at the Investors page of the Company's website. The Full Research Report on CareFusion Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/4933_CFN]
DaVita HealthCare Partners, Inc. Research Report
On October 16, 2013, DaVita HealthCare Partners, Inc. (DaVita) reported that its dialysis division, DaVita has received the Secretary of Defense Employer Support Freedom Award, in recognition of its commitment to supporting National Guard and Reserve employees. "Our commitment is to our community first and a critical part of that is making sure that we support our National Guard and Reserve teammates," said Kent Thiry, CEO of DaVita. "I am honored that we were selected for this award but even prouder that these individuals choose to work for us." The Company stated that he Freedom Award is the Department of Defense' s highest honor for employer support of National Guard and Reserve employees. The Full Research Report on DaVita HealthCare Partners, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/5986_DVA]
MAKO Surgical Corp. Research Report
On October 8, 2013, MAKO Surgical Corp. (MAKO) announced that it has completed the acquisition of Pipeline Biomedical Holdings, Inc.'s (Pipeline) business, which is dedicated to the design, development, manufacture, and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures. MAKO stated that the purchase price for the transaction includes a credit for a cash down payment of $2.5 million, which has been paid to Pipeline earlier, and the issuance at closing of an aggregate of 3.95 million unregistered shares of MAKO's common stock. MAKO further added that since 2010 Pipeline has been MAKO's partner in developing and supplying advanced implant technologies for use with MAKO's RIO Robotic-Arm Interactive Orthopedic system; including the proprietary MAKO-branded RESTORIS PST Cup and Tapered Stem hip implant system for use with the RIO's MAKOplasty Total Hip Arthroplasty software application. The Full Research Report on MAKO Surgical Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/7465_MAKO]
Waters Corporation Research Report
On October 7, 2013, Waters Corporation (Waters) announced the launch of the new Waters ACQUITY QDa Detector, the first mass detector to bring high-quality, mass spectral data to chromatographic separations. Art Caputo, President of Waters Division, said, "The ACQUITY QDa Detector adds a whole new dimension to separation science and it is the most progressive leap forward in chromatography detection since the first photodiode detectors were introduced decades ago." According to Waters, the new Waters ACQUITY QDa Detector is specifically designed for analytical scientists who need mass spectral data without the complexity of a mass spectrometer. The Company added that with the on/off simplicity that analytical scientists have long wanted from mass spectrometry, the ACQUITY QDa Detector completely automates sample analysis and eliminates sample-specific adjustments for certainty in sample results, from user to user and system to system. Waters informed that it has already begun shipping the new mass detector worldwide. The Full Research Report on Waters Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/2fff_WAT]
Health Management Associates, Inc. Research Report
On October 7, 2013, Health Management Associates, Inc. (HMA) announced that its subsidiary has signed a definitive agreement to sell its Williamson Memorial Hospital, located in Williamson, West Virginia to Appalachian Regional Healthcare (ARH), which has its operations in Southern West Virginia and Eastern Kentucky. According to the Company, it expects the transaction to be completed by February 2014. The Full Research Report on Health Management Associates, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/9ce8_HMA]
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner